Ultra-Low PSA Quality Control
Ultra-Low PSA Quality Control


The Acusera ultra-low PSA control delivers a true third party solution for use in monitoring the performance of in vitro diagnostic assays used in the quantitative determination of low levels of PSA.
This control is suitable for use across a variety of platforms.
Name | Unit | Target | Analyser |
Ultra-Low PSA | ng/ml | 0.055 * | Roche Cobas e801 |
* Example of values for Roche Cobas e801. Other systems may vary dependent on laboratory assignment. Typical values displayed, please see control IFU for lot specific values.
Features & Benefits
- Impressive 30-day stability at +2°C to +8°C minimising waste
- Liquid ready-to-use control ensuring minimal sample preparation
- True third-party control providing an unbiased assessment of performance
- Manufactured using human based material providing a matrix similar to the patient sample
- 1 year shelf life from date of manufacture ensuring continuity of lot supply
- Target values for specific instruments are available
This control is for Research Use Only (RUO)
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
Ultra-Low PSA Control | 6 x 1ml | 1 | TU10523 | |
Analyte
- Total PSA
BNP Quality Control


The new Acusera BNP Control is designed for use with in vitro diagnostics assays for the quantitative determination of BNP in human serum and plasma. The BNP control delivers an unbiased independent assessment of analytical performance, helping to ensure accurate and reliable patient testing for BNP.
With a 30 day open-vial stability, the BNP control will reduce waste, whilst remaining easy and convenient to use.
This tri-level control is optimised for use on Beckman, Abbott and Siemens analysers however, it can be used across other platforms. Our control will provide accurate and reliable results that your laboratory can trust.
Features & Benefits
- 30-day stability at +2°C to +8°C minimising waste.
- Liquid ready-to-use control ensuring no preparation of material is required and therefore eliminates manual error.
- True third-party control providing an unbiased assessment of performance.
- Manufactured using human serum providing a matrix similar to the patient sample.
- Optimised for use with Abbott, Beckman and Siemens. Also suitable for use with other platforms.
Description | Pack Size | Analytes | Cat. Number | Contact Us |
---|---|---|---|---|
BNP Controls (Beckman) | 3 x 1 x 1 ml | 1 | CQ10520 | |
BNP Controls (Abbott) | 3 x 1 x 1 ml | 1 | CQ10521 | |
BNP Controls (Siemens) | 3 x 1 x 1 ml | 1 | CQ10522 | |
Analyte
- Brain Natriuretic Peptide (BNP)
QC Data Management Software – Acusera 24.7
Speed up data review and troubleshooting for smarter QC data management.
Designed to complement the Acusera quality control range.
Key Benefits
Instant Alerts
Reduce time spent analysing data with instant identification of QC failures from the last 7 days.
Advanced Statistical Analysis
Automatically calculate advanced statistics including measurement uncertainty, %Bias, Total Error and Sigma Metrics saving time.
24/7 Access
Gain access to this cloud-based software at anytime, anywhere. Removing the need installation, software maintenance and frequent back-ups.
Identify Trends and Bias
At a glance performance assessment with customisable Levey-Jennings, Histograms and Performance Summary Charts.
Peer Group Statistics
Updated in real-time, labs can compare statistics to their peers to help reduce time and money spent on troubleshooting.
Automated Data Import
Upload QC data directly to Acusera 24•7 via LIMS and middleware. This automated function eliminates the need for manual data entry and helps save money whilst increasing efficiency.
Comprehensive Reports
Comprehensive, easy-to-read reports designed to speed up the data review process.
Highly Flexible
Labs can configure their own performance limits, multi-rules, consensus groups and target values for each instrument or lot of QC.
Technical Support
Expert technical support is available for users. Laboratories can access this service for troubleshooting purposes and therefore eliminates the need for on-site assistance.
Features of Acusera 24•7
Our intelligent user interface enables rapid review of QC data and identification of QC failures.
The new and improved home screen allows users to carry out tasks such as: Creation of new tests/panels | Filtering results by analyte/ instrument/ lot number | Entering single or several QC test(s) without having to navigate away to multiple areas within the application.
Specifically designed to speed up the review process, our comprehensive range of easy-to read reports include: Data Review | Exception Report | Statistical Analysis Report | Statistical Metrics Report
Customise reports to show data for a specific date range aswell as a particular test or instrument.
Instant access to interactive Levey-Jennings, Histogram and Performance Summary Charts as well as the ability to add events and multiple data sets to a single chart allows for swift performance monitoring and superior identification of trends across multiple instruments.
One location for all of your statistical analysis needs.
What The Users Say:
“We have been using 24.7 as our QC data management solution for some time now after changing from a different provider. Acusera 24.7 has become part and parcel of everyday QC monitoring and management. From the ease of use of configuring new instruments, assays, panels and lot numbers to the plethora of data that can be extracted to aid in optimal QC data management, Acusera 24.7 offers the flexibility to adapt to any user organisation.”
Nuffield Health – United Kingdom
Resources
How To Guide: Logging in
How To Guide: Adding Events
How To Guide: Adding QC Panel
How To Guide: Adding QC Tests
How To Guide: Chart Generation and Overview
How To Guide: Data Entry Options
How To Guide: Exception Report
How To Guide: Home Page
How To Guide: Manual Data Entry
How To Guide: Navigating Side Bars
How To Guide: Peer Group Statistics
How To Guide: Result History
How To Guide: Statistical Analysis Report
How To Guide: Statistical Metrics Report
How To Guide: Uncertainty of Measurement
Continue Reading
Acusera 24•7 FAQs
Acusera 24•7 Login
24•7 Brochure
Contact Us
Laboratory Quality Control – Acusera
Complete laboratory quality control solutions designed to save time & money whilst delivering patient results you can trust.

Key Benefits
Superior Cost Savings
Save money, time and workload by streamlining QC proccesses.
Highly Commutable
Accurate performance evaluation with QC that mimics patient samples.
Clinically Relevant Levels
Ensure accurate instrument performance and patient results.
True Third Party Controls
Independent controls for use on multiple instrument platforms.
Unrivalled Stability
Longer working stability, minimising waste and lowering QC costs.
Advanced QC Data Management
Automate data management and ensure regulatory compliance.
Internal Laboratory Quality Control Range
With over 390 parameters, choice and flexibility is guaranteed.
Browse the controls below

What Are The Benefits of Third Party Controls?


Customer Testimonials


Continue Reading
Laboratory Quality Control Brochure
Importance of Third Party QC
Acusera 24•7 QC Data Management
Contact Us
Anti-Müllerian Hormone (AMH) Quality Control


The Randox Acusera AMH control is designed for use as a third-party control for the quantitative determination of Anti-Müllerian Hormone (AMH). An AMH test is often used to check a woman’s ability to produce eggs that can be fertilized for pregnancy. Thus, helping women to make informed decisions about their health.
Available in a liquid frozen format, this control should be treated in the same manner as a patient sample.
Features & Benefits
- 30-day stability at +2°C to +8°C
- Liquid Frozen format for convenience and reduced handling errors
- True third-party control providing an unbiased assessment of performance
- Manufactured using human serum, ensuring commutable sample matrix
- Assayed target values provided eliminating the need to assign values in-house
- Control available at recommended cut-off values for AMH
Description | Pack Size | Cat. Number | Typical Values Beckman DXL / Roche ng/ml | |
---|---|---|---|---|
AMH Control 1 | 3 x 2ml | AMH10509 | 0.5 | |
AMH Control 2 | 3 x 2ml | AMH10514 | 1.0 | |
AMH Control 3 | 3 x 2ml | AMH10515 | 6.0 | |
AMH Control 4 | 3 x 2ml | AMH10516 | 16.0 |
Analyte
- Anti-Müllerian Hormone (AMH)
Serum Indices Quality Control

The Randox Acusera Serum Indices control is designed to be used to monitor an IVD instrument’s response in the detection of haemolyzed, icteric and lipemic (HIL) samples. This control can be utilised in laboratory interference testing to assist in improving error detection of pre-analytical errors affecting clinical chemistry testing.
This control provides a full range of clinically relevant testing levels, including a negative (-) and three positives (+, ++ & +++)
Features & Benefits
- Lyophilised for enhanced stability
- Manufactured using human serum, ensuring commutable sample matrix
- 2-year shelf life from date of manufacture
- True third party control providing unbiased assessment of performance
- Reconstituted stability of 14 days at 2°C – 8°C
- 4 separate levels available including -, +, ++ & +++
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
Serum Indices Control | 4 x 5 ml | 3 | SI10448 | |
Analytes
- Haemolysis (H)
- Icterus (I)
- Lipemia (L)
Randox International Quality Assessment Scheme (RIQAS)
RIQAS is the world’s largest EQA scheme with more than 76,000 laboratory participants spanning over 140 countries.
Key Benefits
Cost Effective
Reduce the number of EQA programmes required to cover your test menu whilst saving time and costs.
Flexible EQA Programme Options
Flexible EQA programme options to suit all laboratory budgets. Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment.
Accredited
EQA programmes accredited to ISO/IEC 17043:2010 “Conformity Assessment – General Requirements for Proficiency Testing”. Please see accreditation schedule for additional information.
Large Peer Group
As the world's largest EQA provider more robust data is available for a wider range of instruments and methods.
Rapid, User-Friendly EQA Reports
Our rapid, user-friendly EQA reports allow at-a-glance performance assessment. Complimentary multi-instrument, inter-laboratory and end-of-cycle reports available.
Commutable Sample Matrxi
A commutable sample matrix increases confidence that performance mimics that of patient samples.
Early Identification of Errors
Frequent reporting allows early identification of test system errors, while our rapid report turnaround enables corrective action to be taken sooner.
Clinically Relevant Samples
EQA samples designed to span clinically relevant levels ensuring accurate performance assessment at medical decision limits.
Convenient Data Upload System
RIQAS.net is a convenient, web-based data entry system which allows participants to return results and view reports online.
RIQAS EQA Programmes
Choice & flexibility are guaranteed with our 38 programme portfolio.
Browse the programmes below
RIQAS EQA Reports
User-friendly, one-page per parameter reports allow for at-a-glance performance assessment.
Browse the reports below.
What Does RIQAS Provide?

RIQAS Calendar 2025
What the Participants say:
“EcoScense LLC joined RIQAS in 2015 and currently run the General Clinical Chemistry, Haematology and Microbiology Programmes. We chose RIQAS as it is the best quality and has the most accessible programmes with weekly and monthly reporting available. We are very satisfied with the service and support we receive from the Randox team.”
EcoSenseLLC – Armenia
“Alfa Diagnostica have been participating in RIQAS for 6 years. Over this time, the number of EQA programmes has increased from 4 to 12. We chose RIQAS because of its quality, well-thought-out programmes, convenient scheduling and the large number of participants. RIQAS has enhanced the quality of our services by providing a flexible, convenient and objective solution for self-evaluation. It has served as proof of reliable results for any interested third party.”
Alfa Diagnostica SRL – Republic of Moldova
Continue Reading
RIQAS EQA Brochure
RIQAS EQA Parameters
RIQAS.net
RIQAS Calendar
Contact Us
RIQAS Past Panels
RIQAS (Randox International Quality Assessment Scheme) is the largest global EQA scheme with over 76,000 participants in more than 139 countries. Our range currently comprises 36 programmes and the majority of clinical testing.
What are RIQAS Past Panels?
Available Panels
• Ammonia/ Ethanol
• Anti-Müllerian Hormone (AMH)
• Anti-TSH Receptor
• Blood Gas
• BNP
• Cardiac
• Cardiac Plus
• Cerebrospinal Fluid (CSF)
• Coagulation
• CO-Oximetry
• CYFRA 21-1
• Cytokines
• General Clinical Chemistry
• Glycated Haemoglobin (HbA1c)
• Human Urine
• Immunoassay
• Immunoassay Speciality 1
• Immunoassay Speciality 2
• Immunosuppressant
• Lipid
• Maternal Screening
• Microbiology (Bacterial Identification)
• Neonatal Bilirubin
• Pre-eclampsia
• Serology Chagas
• Serology (EBV)
• Serology (HIV/ Hepatitis)
• Serology (Syphilis)
• Serology (ToRCH)
• Serum Indices
• Specific Proteins
• Sweat Testing
• Therapeutic Drugs
• Urinalysis
• Urine Toxicology
*Product availability is dependent on RIQAS stock surplus levels.
Benefits of RIQAS Past Panels
All RIQAS Past Panels are provided with an Excel document containing supporting data for the instrument and method of interest.
RIQAS Past Panel samples span multiple levels, making them ideal for ensuring accurate instrument performance across the measuring range.
RX series (Concept 3)

The RX series range of clinical chemistry analysers includes both semi-automated and fully automated testing for a range of clinical settings. With a world leading test menu comprising of routine chemistries, specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants and diabetes testing, the RX series offers laboratories the complete clinical chemistry package and results you can trust. The RX series was built with three core values in mind – Reliability, Accuracy and Precision.
Consolidation of Routine & Specialised Testing on One Single Platform
With an extensive product portfolio covering over 100 disease markers within routine and nice testing, the RX series removes the need for a separate nephelometry system for specific proteins and allows laboratories to bring all testing in-house; thus ensuring minimal downtime and providing real cost savings through consolidation.
Low Reagents & Sample Volumes
Built with excellence in mind, the RX series range of analsyers require a low sample volume to deliver consistent high quality results which is beneficial when working with paediatric patients and animals. Combined with our high quality reagents, the RX series reduce the possibility of misdiagnoses, offering accurate, reliable and precise results each time, every time.
Unrivalled Customer Support
Our team of trained engineers are on hand to work with you in preserving the continuity of your operations while maximising the potential of your RX series instrument. We know time is critical in any laboratory and our global network means we are uniquely positioned to meet your needs with local service and support whenever you need it.
Fully Automated
Test Menu
Semi-Automated
Test Menu
Niche
Test Menu
QCMD – Molecular EQA
QCMD is a world leading Molecular EQA / Proficiency Testing scheme specialising in infectious disease testing.
With an extensive database of over 15,000 participants in over 120 countries, QCMD is one of the largest providers of molecular EQA.
Blood Borne Viruses
Central Nervous System Diseases
Drug Resistance
Exotic / Emerging Diseases
Gastrointestinal Diseases
Immunocompromised Associated Diseases
Multiple Pathogen / Syndromic Infections
Respiratory Diseases
Serology
Sexually Transmitted Infections
Transplant Associated diseases
Typing
New Pilot Studies

After the close of the results return phase, EQA participants will receive an individual report outlining their performance relative to their method and technology groups. A supplementary report may be commissioned – this includes any additional relevant information regarding the annual EQA distribution, as well as scientific expert commentary and feedback on the overall results within that distribution.
*Randox are authorised by QCMD to provide the QCMD EQA schemes under a strategic global partnership. The EQA design, composition, data analysis & reporting remain the responsibility of QCMD. Please refer to specific geographical regions for further details on availability.
Explore Further